Janus Henderson Global Life Sciences Fund (JAGLX) Stock Overview
Explore Janus Henderson Global Life Sciences Fund’s financial performance, market position, analyst ratings, and future outlook.
Janus Henderson Global Life Sciences Fund (JAGLX)
Key Financials
Key Financials
Market Cap
5.8B
P/E Ratio
N/A
EPS (TTM)
$2.99
ROE
N/A
JAGLX Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Janus Henderson Global Life Sciences Fund's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of JAGLX on the NASDAQ shows an RSI of 51.16, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $88.69 for the NASDAQ listing.
Key metrics behind Janus Henderson Global Life Sciences Fund's NASDAQ-traded stock include a P/E ratio of N/A and a market capitalization of 5.8B. Combined with our AI analysis, these give both institutional and retail investors a clear view of JAGLX on the NASDAQ.